DE50105139D1 - Oxazinderivate - Google Patents

Oxazinderivate

Info

Publication number
DE50105139D1
DE50105139D1 DE50105139T DE50105139T DE50105139D1 DE 50105139 D1 DE50105139 D1 DE 50105139D1 DE 50105139 T DE50105139 T DE 50105139T DE 50105139 T DE50105139 T DE 50105139T DE 50105139 D1 DE50105139 D1 DE 50105139D1
Authority
DE
Germany
Prior art keywords
reactive group
test material
binding
contain
phenazoxonium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE50105139T
Other languages
German (de)
English (en)
Inventor
Joachim Fries
Eloisa Lopez-Calle
Karl-Heinz Drexhage
Dirk Winkler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Evotec OAI AG
Original Assignee
Evotec OAI AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP00127005A external-priority patent/EP1213328A1/de
Application filed by Evotec OAI AG filed Critical Evotec OAI AG
Application granted granted Critical
Publication of DE50105139D1 publication Critical patent/DE50105139D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/341,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09BORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B19/00Oxazine dyes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • G01N33/532Production of labelled immunochemicals
    • G01N33/533Production of labelled immunochemicals with fluorescent label

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Flanged Joints, Insulating Joints, And Other Joints (AREA)
DE50105139T 2000-09-06 2001-09-05 Oxazinderivate Expired - Lifetime DE50105139D1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00119292 2000-09-06
EP00127005A EP1213328A1 (de) 2000-12-08 2000-12-08 Oxazinderivate
PCT/EP2001/010236 WO2002020670A1 (de) 2000-09-06 2001-09-05 Oxazinderivate

Publications (1)

Publication Number Publication Date
DE50105139D1 true DE50105139D1 (en) 2005-02-24

Family

ID=26071369

Family Applications (1)

Application Number Title Priority Date Filing Date
DE50105139T Expired - Lifetime DE50105139D1 (en) 2000-09-06 2001-09-05 Oxazinderivate

Country Status (6)

Country Link
US (2) US7101999B2 (https=)
EP (2) EP1535967B1 (https=)
JP (1) JP2004508448A (https=)
AT (2) ATE518913T1 (https=)
DE (1) DE50105139D1 (https=)
WO (1) WO2002020670A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE518913T1 (de) 2000-09-06 2011-08-15 Evotec Ag Verfahren zur gezielten markierung mittels affinitätsmarkierter detektionsmarker
DE10212960A1 (de) * 2002-03-22 2003-10-23 Gnothis Holding Sa Ecublens Verwendung von Oxazin-Farbstoffen als Markierungsgruppen für die Einzelmolekülanalyse
BRPI0413703A (pt) * 2003-08-18 2006-10-17 Novartis Ag derivados de 3h-fenoxazina adequados como agentes formadores de imagem do infravermelho próximo, preparação e uso dos mesmos
EP1607393A1 (fr) * 2004-06-18 2005-12-21 L'oreal Compositions comprenant des colorants directs hydroxyalkyles, procédés de mise en oeuvre et utilisations.
US7326258B2 (en) * 2004-06-18 2008-02-05 L'oreal S.A. Compositions comprising hydroxyalkyl direct dyes, implementation processes and uses thereof
US8187825B2 (en) 2008-02-29 2012-05-29 Riken Thiol detection method
US20120010404A1 (en) * 2008-06-10 2012-01-12 Sigma-Aldrich Co. Oxazine dyes with improved aqueous solubility
GB0903348D0 (en) * 2009-02-27 2009-04-08 Pharmalucia Ltd Compounds and methods relating thereto
CN103044947B (zh) * 2013-01-09 2014-05-21 大连理工大学 一类尼罗蓝荧光染料,其制备方法及应用
US11077210B2 (en) 2013-10-31 2021-08-03 Beth Israel Deaconess Medical Center Near-infrared fluorescent contrast bioimaging agents and methods of use thereof
US11001562B2 (en) 2013-10-31 2021-05-11 Beth Israel Deaconess Medical Center Near-infrared fluorescent nerve contrast agents and methods of use thereof
US12440585B2 (en) 2023-09-12 2025-10-14 Curadel Surgical Innovations, Inc. Zwitterionic metal chelators

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE287040C (https=)
US1488609A (en) * 1924-04-01 murphy
JPS501576B2 (https=) * 1972-04-25 1975-01-20
GB1410815A (en) * 1972-12-20 1975-10-22 Ici Ltd Oxazine dyestuffs
DE2411761A1 (de) * 1974-03-12 1975-10-16 Hoechst Ag Basische oxazinfarbstoffe, verfahren zu ihrer herstellung und ihre verwendung
US4622395A (en) * 1984-10-01 1986-11-11 Minnesota Mining And Manufacturing Company Phenoxazine and phenothiazine dyes and leuco forms thereof
US4714763A (en) 1985-07-11 1987-12-22 Viomedics Inc. Novel oxazine-ureas and thiazine urea chromophors as fluorescent labels
US4780535A (en) * 1986-11-21 1988-10-25 Spyros Theodoropulos Maleic and phthalic diamides
US4965349A (en) 1987-12-24 1990-10-23 Applied Biosystems, Inc. Method of synthesizing oligonucleotides labeled with ammonia-labile groups on solid phase supports
US4962197A (en) * 1988-02-12 1990-10-09 Rowland Institute For Science Photo-inactivation of cancer cells
IL91673A0 (en) * 1988-09-20 1990-04-29 Us Health Method for tagging an oligodeoxynucleotide
DD287040A5 (de) * 1989-07-28 1991-02-14 Veb Forschungszentrum Biotechnologie Berlin,De Neue fluophorderivate, verfahren zu ihrer herstellung und deren verwendung zur herstellung neuartiger fluoreszenzmarkierter nucleoside, nucleotide und oligonucleotide
GB9024775D0 (en) * 1990-11-14 1991-01-02 Axis Research Chemical compounds
US5344928A (en) 1991-04-26 1994-09-06 Takeda Chemical Industries, Ltd. Phenothiazine derivatives, their production and use
JPH05170752A (ja) * 1991-04-26 1993-07-09 Takeda Chem Ind Ltd 3,7−ビス(ジ置換アミノ)フェノチアジン誘導体およびその製造法
DE59309805D1 (de) 1992-12-15 1999-11-04 Ciba Sc Holding Ag Oxazinfarbstoffe, Verfahren zu deren Herstellung und deren Verwendung
US5656759A (en) 1993-07-22 1997-08-12 Sony Corporation Hydrophobic cationic dye compounds
US5792389A (en) * 1993-10-27 1998-08-11 United States Of America Water soluble laser dyes
US5620842A (en) * 1995-03-29 1997-04-15 Becton Dickinson And Company Determination of the number of fluorescent molecules on calibration beads for flow cytometry
DE19521231A1 (de) * 1995-06-10 1996-12-12 Boehringer Mannheim Gmbh Neue Oxazinfarbstoffe und ihre Verwendung als Fluoreszenzmarker
GB9602265D0 (en) * 1996-02-05 1996-04-03 Amersham Int Plc Benzophenoxazine dyes
GB9716476D0 (en) * 1997-08-04 1997-10-08 Amersham Int Plc Dye intermediate and method
FR2780791B1 (fr) 1998-07-03 2000-09-01 Bio Merieux Methode de depistage ou de diagnostic d'un adenocarcinome ou d'une pathologie benigne de la prostate et procede de mise en oeuvre
US6140500A (en) * 1999-09-03 2000-10-31 Pe Corporation Red-emitting [8,9]benzophenoxazine nucleic acid dyes and methods for their use
US6727356B1 (en) * 1999-12-08 2004-04-27 Epoch Pharmaceuticals, Inc. Fluorescent quenching detection reagents and methods
US6465644B1 (en) * 2000-05-02 2002-10-15 Applera Corporation Sulfonated [8,9] benzophenoxazine dyes and the use of their labelled conjugates
ATE518913T1 (de) 2000-09-06 2011-08-15 Evotec Ag Verfahren zur gezielten markierung mittels affinitätsmarkierter detektionsmarker
EP1337851B1 (de) * 2000-11-16 2005-07-20 Roche Diagnostics GmbH Farbstoffpaare für fluoreszenz-resonanz-energie-transfer (fret) messungen

Also Published As

Publication number Publication date
EP1535967B1 (de) 2011-08-03
EP1535967A1 (de) 2005-06-01
JP2004508448A (ja) 2004-03-18
US20040029837A1 (en) 2004-02-12
US7101999B2 (en) 2006-09-05
US20060240455A1 (en) 2006-10-26
ATE287430T1 (de) 2005-02-15
WO2002020670A1 (de) 2002-03-14
ATE518913T1 (de) 2011-08-15
EP1317511B1 (de) 2005-01-19
EP1317511A1 (de) 2003-06-11

Similar Documents

Publication Publication Date Title
DE50105139D1 (en) Oxazinderivate
MY141224A (en) Crystalline form of a biphenyl compound
DE69512797D1 (en) Prostaglandin-synthase hemmer
EA200000334A1 (ru) Производные карбоксамидотиазолов, их получение, содержащие их фармацевтические композиции
BR9509665A (pt) Composto composições e métodos
PT982398E (pt) Acidos nucleicos e suas utilizacoes no teste de beta-lactamase
ZA200102057B (en) Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof.
HUP9902576A1 (hu) Új eritromicinszármazékok, eljárás előállításukra és alkalmazásuk gyógyászati készítményekben
GB9916405D0 (en) Compounds for mass spectrometry
PT1250340E (pt) Metodos e compostos para inibicao de mrp1
BR9914787A (pt) Processo para a preparação de um composto
DE69918465D1 (de) Sulfonamidhydroxamate
ATE149164T1 (de) Neue tetrazolderivate, verfahren zu ihrer herstellung und ihre verwendung
DE60001979D1 (de) Neue Substrate zur Detektion von mikrobiellen Metaboliten
DE69735845D1 (de) Kristalle von vitamin d derivaten und verfahren zu ihrer herstellung
ES8303350A1 (es) Procedimiento para preparar derivados de piridina.
NO833648L (no) Fenylinderivater, syreaddisjonssalter derav og fremgangsmaater ved fremstilling av disse
DE69824855D1 (de) Macrozyklische laktone, zusammensetzungen und verfahren zur verwendung
BG103398A (en) New derivatives of erythromicyn, method for their preparation and application as medicmentous forms
EP0549352A3 (en) Tricyclic compounds as angiotensin ii antagonists
WO2002000624A3 (en) Methods and compounds for inhibiting mrp1
ES2188464T3 (es) Procedimiento para la obtencion de esteres de n-acil-aminoacidos y n-acil-aminoacetales.
AU2001260220A1 (en) Method for modification of proteins by transglutaminase
WO1998034917A3 (en) Synthesis of acyclic nucleoside derivatives
BG106916A (bg) Метод за получаване на естери на арил-иминометил-карбаминова киселина

Legal Events

Date Code Title Description
8364 No opposition during term of opposition